In vivo emergence of ceftaroline resistance during therapy for MRSA vertebral osteomyelitis

J Antimicrob Chemother. 2016 Jun;71(6):1736-8. doi: 10.1093/jac/dkw001. Epub 2016 Feb 9.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use*
  • Ceftaroline
  • Cephalosporin Resistance*
  • Cephalosporins / pharmacology
  • Cephalosporins / therapeutic use*
  • Genes, Bacterial
  • Humans
  • Male
  • Methicillin-Resistant Staphylococcus aureus / drug effects*
  • Methicillin-Resistant Staphylococcus aureus / genetics
  • Methicillin-Resistant Staphylococcus aureus / isolation & purification
  • Middle Aged
  • Mutation
  • Sequence Analysis, DNA
  • Spondylitis / drug therapy*
  • Staphylococcal Infections / drug therapy*
  • Staphylococcal Infections / microbiology*

Substances

  • Anti-Bacterial Agents
  • Cephalosporins
  • Ceftaroline